ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Endovascular

June 22, 2020
Over the years, frozen elephant trunk (FET) has become the treatment of choice for multisegmental thoracic aortic disease.
May 6, 2020
Use of anatomic abbreviations instead of numbers seems pro-intuitive ...
March 1, 2020
A very easy-to-read editorial that digests a manuscript on the IMPROVE study.
January 29, 2020
In this consensus statement, a new anatomic classfication system is proposed for thoracic aortic dissections.  The acuity of aortic dissection and complicated vs uncomplicated dissections are clearly defined.  Risk factors, presentations, management, and complications are expounded.  Follow-up criteria are also discussed with nomenclature for false l
November 11, 2019
A succinct analysis of a challenging problem, with a discussion on the 'magic diameter' of 55 mm.
October 6, 2019
An important and recent consensus update.
August 3, 2019
In this brief review, the authors elaborate on status quo of the use of endovascular stent grafts in the management of patients with connective tissue disorders. Because the radial force and circumferential stress on the native aorta remains a signficant issue that leads to stent graft failure, open surgical repair remains the gold standard in most o
June 16, 2019
Thoracoabdominal aortic aneurysm (TAAA) repair began in Houston, Texas, with  pioneer surgeons such as Drs Michael E. DeBakey, Denton A. Cooley, and E. Stanley Crawford. Their early attempts to repair TAAA were complicated by risk of renal and spinal cord ischemia and difficulty in reattaching the branching vessels of the thoracoabdominal aorta.
June 2, 2019
The NEJM published the long-term results of the OVER study of open repair (OR) versus endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm (AAA) on May 30.
April 19, 2019
At the Charing Cross Symposium, held April 15 to 18 in London, UK, Professor Fabio Verzini presented the 30-day data from Medtronic's Valiant Navion investigational device exemption study of 100 patients with thoracic aortic aneurysm and penetrating atherosclerotic ulcer.

Pages